5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A vaccine against HTLV-1 HBZ makes sense.

      1

      Blood

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this issue of Blood, Sugata et al report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper (bZIP) factor (HBZ) could be used for immunotherapy in adult T-cell leukemia-lymphoma (ATL) patients.

          Related collections

          Author and article information

          Journal
          Blood
          Blood
          1528-0020
          0006-4971
          Aug 27 2015
          : 126
          : 9
          Affiliations
          [1 ] EQUIPE LABELISÉE LIGUE CONTRE LE CANCER, INSERM U1111-CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UMR5308.
          Article
          126/9/1052
          10.1182/blood-2015-06-652040
          26316613

          Comments

          Comment on this article